Why Most Site Registries Don't Produce Enrollments
A registry only produces enrollments when it answers specific eligibility questions, stays current, and has a named owner. Here's how to build and maintain one that works.
By Trialflow Team
Most sites have a registry. Fewer have a registry that produces enrollments. The difference is rarely the software — it's what you collect, how often you touch it, and whether anyone owns it.
A registry is a relationship list, not a contact list
The common failure mode: a spreadsheet of everyone who ever called, with a name, phone number, and the study they didn't qualify for in 2022. When a new protocol opens, someone blasts the whole list, gets a handful of replies and a few annoyed unsubscribes, and concludes registries don't work.
A registry works when you can answer a specific question quickly: who in our database is a postmenopausal woman with an A1c over 8 who lives within 25 miles and has told us she's willing to do monthly visits? If your data can't answer that, you have a contact list.
Collect the fields that drive eligibility in your therapeutic areas
Don't try to capture everything. Look at the last two years of protocols at your site and pull the inclusion criteria that actually gate enrollment. For most sites that's a short list:
- Age and sex
- Primary conditions and year of diagnosis
- Current medications in the relevant class
- Key lab values with the date they were taken
- Prior study participation and washout status
- Travel radius and transportation needs
- Visit-schedule tolerance (can they do weekly? overnight?)
- Contact preference and best time of day
Add a free-text note field for things that don't fit a column — a caregiver's name, a hesitation about blood draws, the fact that they can only come on Thursdays. Coordinators use these notes more than any structured field.
Build the registry from sources you already have
You do not need a campaign to start one. Most sites are sitting on several feeders:
- Screen failures. The richest source. Someone who failed on one lab value is pre-qualified on everything else. Capture the failure reason in a structured field, not prose.
- Completers. People who finished a study and liked the experience are your highest-converting group. Ask for registry consent at the final visit, while goodwill is highest.
- Inbound callers for closed studies. They raised their hand once.
- Community events and health screenings. Lower quality, but volume.
Whatever the source, get documented permission to contact them for future research. Check your IRB's position — many require a separate registry consent or a specific HIPAA authorization. Build that into intake rather than retrofitting later.
Keep it alive with light, regular contact
Registries decay. Phone numbers change, people move, conditions progress. Plan on touching every record at least twice a year with something that isn't a recruitment ask — a short health-topic email, a note about studies your site has open, an annual "is your information still current?" message with a one-click update link.
This matters for a practical reason: when a protocol opens with a two-week enrollment window, the registry you contacted last month converts. The one you haven't touched in 18 months mostly bounces.
Assign an owner
The single best predictor of whether a registry produces is whether one named person is responsible for it. Give that person a standing weekly block — an hour is enough — to add new records, resolve duplicates, and work the update queue. Without a defined owner, registry maintenance becomes the task that loses every week to visit coverage and monitor visits.
Start narrow. One therapeutic area, twenty well-documented fields, four hundred clean records you've actually contacted in the last six months beats five thousand stale rows every time.
Enrolling studies shouldn't be this hard
Trialflow gives research sites one platform for lead management, AI trial matching, and recruitment analytics.
Request a Demo